Alzheimer community between disappointment and hope regarding drug development at CTAD conference 2016

Executive Director Marc Wortmann reviews progress in new drug developments for Alzheimer’s Disease at the 9th Clinical Trials in Alzheimer’s Disease Conference (CTAD) in December 2016. … More Alzheimer community between disappointment and hope regarding drug development at CTAD conference 2016